Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 30, 2026 08:00 ET | Source: Quince Therapeutics, Inc.

Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board

SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease...
June 30, 2026 08:00 ET | Source: Genelux Corporation

Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer

- Findings provide mechanistic support for previously reported clinical outcomes of clinical reversal of platinum resistance/refractoriness from Phase 2 VIRO-15 trial - - Data demonstrate...
June 30, 2026 08:00 ET | Source: Cogent Biosciences, Inc.

Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)

Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria with a well-tolerated...
June 30, 2026 08:00 ET | Source: Akebia Therapeutics, Inc.

U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA

Vafseo® demonstrated a clinically meaningful safety outcome benefit in U.S. patients with anemia due to CKD on dialysis utilizing TIW dosing regimen Primary Investigator to stop trial on...
June 30, 2026 08:00 ET | Source: Design Therapeutics, Inc.

Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1

GeneTAC® small molecule designed to selectively reduce transcription of the mutant DMPK allele and address the underlying cause of DM1 CARLSBAD, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Design...
June 30, 2026 07:30 ET | Source: Pyxis Oncology

Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

Expected to extend cash runway into the second quarter of 2027, supporting additional follow-up for 2L+ R/M HNSCC patients treated with MICVO at or below a dose cap Company now expects updated Phase...
June 30, 2026 07:05 ET | Source: Unicycive Therapeutics, Inc.

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

-- Complete Response Letter relates to deficiencies previously identified at third-party manufacturing vendor -- -- FDA inspection of third-party facility did not occur during the NDA resubmission...
June 30, 2026 05:32 ET | Source: Intravacc B.V.

Intravacc Highlights Four Integrated Vaccine Development Platforms for CDMO Partners

Intravacc Highlights Four Integrated Vaccine Development Platforms for CDMO Partners
June 30, 2026 05:30 ET | Source: Salipro Biotech AB

Salipro Biotech Announces Publication in Nature Scientific Reports on Expanding DEL Screening to Membrane Proteins

Salipro Biotech and collaborators unlock DNA‑Encoded Library screening for challenging membrane protein targets, expanding drug discovery possibilities.
June 30, 2026 03:00 ET | Source: Cure 4 The Kids Foundation

American Idol, The Voice Finalists Lend Their Voices To Special Holiday Anthem Benefiting Childhood Cancer Warriors

Las Vegas, June 30, 2026 (GLOBE NEWSWIRE) -- American Idol Finalists Mackenzie Sol, Drew Ryn, Maryjo Young, Amanda Barise, and Samoan Silk along with former member of Why Don’t We, Jonah Marais, The...